Mark H. Criswell

540 total citations
19 papers, 448 citations indexed

About

Mark H. Criswell is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark H. Criswell has authored 19 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 9 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark H. Criswell's work include Retinal Diseases and Treatments (10 papers), Retinal Development and Disorders (8 papers) and Retinal and Optic Conditions (5 papers). Mark H. Criswell is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Retinal Development and Disorders (8 papers) and Retinal and Optic Conditions (5 papers). Mark H. Criswell collaborates with scholars based in United States, Israel and United Kingdom. Mark H. Criswell's co-authors include Thomas A. Ciulla, Christopher Brandon, David A. Goss, Donald S. Fong, Jonathan D. Walker, Ronald P. Danis, Wenzheng Hu, Grant M. Comer, Jon I. Williams and Kenneth J. Holroyd and has published in prestigious journals such as Brain Research, Vision Research and Investigative Ophthalmology & Visual Science.

In The Last Decade

Mark H. Criswell

19 papers receiving 422 citations

Peers

Mark H. Criswell
Yiwen Li China
Mark H. Criswell
Citations per year, relative to Mark H. Criswell Mark H. Criswell (= 1×) peers Yiwen Li

Countries citing papers authored by Mark H. Criswell

Since Specialization
Citations

This map shows the geographic impact of Mark H. Criswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Criswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Criswell more than expected).

Fields of papers citing papers by Mark H. Criswell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Criswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Criswell. The network helps show where Mark H. Criswell may publish in the future.

Co-authorship network of co-authors of Mark H. Criswell

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Criswell. A scholar is included among the top collaborators of Mark H. Criswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Criswell. Mark H. Criswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hu, Wenzheng, Mark H. Criswell, Shao‐Ling Fong, et al.. (2008). Differences in the temporal expression of regulatory growth factors during choroidal neovascular development. Experimental Eye Research. 88(1). 79–91. 38 indexed citations
2.
Criswell, Mark H.. (2008). Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model. Archives of Ophthalmology. 126(7). 946–946. 14 indexed citations
3.
Fong, Shao‐Ling, Mark H. Criswell, Teri L. Belecky‐Adams, et al.. (2005). Characterization of a transgenic mouse line lacking photoreceptor development within the ventral retina. Experimental Eye Research. 81(4). 376–388. 4 indexed citations
4.
Hu, Wenzheng, Mark H. Criswell, Anna Ottlecz, et al.. (2005). ORAL ADMINISTRATION OF LUMIRACOXIB REDUCES CHOROIDAL NEOVASCULAR MEMBRANE DEVELOPMENT IN THE RAT LASER-TRAUMA MODEL. Retina. 25(8). 1054–1064. 24 indexed citations
5.
Comer, Grant M., Thomas A. Ciulla, Jeffrey S. Heier, & Mark H. Criswell. (2005). Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration. Expert Opinion on Emerging Drugs. 10(1). 119–135. 5 indexed citations
6.
Criswell, Mark H., et al.. (2005). Anastomotic Vessels Remain Viable after Photodynamic Therapy in Primate Models of Choroidal Neovascularization. Investigative Ophthalmology & Visual Science. 46(6). 2168–2168. 10 indexed citations
7.
Ciulla, Thomas A., Jonathan D. Walker, Donald S. Fong, & Mark H. Criswell. (2004). Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Current Opinion in Ophthalmology. 15(3). 211–220. 83 indexed citations
8.
Comer, Grant M., Thomas A. Ciulla, Mark H. Criswell, & Michael J. Tolentino. (2004). Current and Future Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration. Drugs & Aging. 21(15). 967–992. 27 indexed citations
9.
Ciulla, Thomas A., Mark H. Criswell, Ronald P. Danis, Wendy Snyder, & Ward Small. (2004). EVALUATION OF PHOTOPOINT PHOTOSENSITIZER MV6401, INDIUM CHLORIDE METHYL PYROPHEOPHORBIDE, AS A PHOTODYNAMIC THERAPY AGENT IN PRIMATE CHORIOCAPILLARIS AND LASER-INDUCED CHOROIDAL NEOVASCULARIZATION. Retina. 24(4). 521–529. 6 indexed citations
10.
Criswell, Mark H., et al.. (2004). The Squirrel Monkey: Characterization of a New-World Primate Model of Experimental Choroidal Neovascularization and Comparison with the Macaque. Investigative Ophthalmology & Visual Science. 45(2). 625–625. 12 indexed citations
11.
Danis, Ronald P., Mark H. Criswell, Faruk Örge, et al.. (2003). Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization. Current Eye Research. 26(1). 45–54. 18 indexed citations
12.
Ciulla, Thomas A., Mark H. Criswell, Ronald P. Danis, et al.. (2003). Squalamine Lactate Reduces Choroidal Neovascularization in a Laser-Injury Model in the Rat. Retina. 23(6). 808–814. 46 indexed citations
13.
Rechtman, E., Thomas A. Ciulla, Mark H. Criswell, Ayala Pollack, & Alon Harris. (2002). An update on photodynamic therapy in age-related macular degeneration. Expert Opinion on Pharmacotherapy. 3(7). 931–938. 30 indexed citations
14.
Brandon, Christopher & Mark H. Criswell. (1995). Displaced starburst amacrine cells of the rabbit retina contain the 67-kDa isoform, but not the 65-kDa isoform, of glutamate decarboxylase. Visual Neuroscience. 12(6). 1053–1061. 25 indexed citations
15.
Criswell, Mark H. & Christopher Brandon. (1993). Acetylcholinesterase and choline acetyltransferase localization patterns do correspond in cat and rat retinas. Vision Research. 33(13). 1747–1753. 17 indexed citations
16.
Criswell, Mark H. & Christopher Brandon. (1992). Cholinergic and GABAergic neurons occur in both the distal and proximal turtle retina. Brain Research. 577(1). 101–111. 23 indexed citations
17.
Criswell, Mark H. & David A. Goss. (1983). Myopia Development in Nonhuman Primates—A Literature Review. Optometry and Vision Science. 60(3). 250–250. 32 indexed citations
18.
Goss, David A. & Mark H. Criswell. (1981). Myopia Development in Experimental Animals—A Literature Review. Optometry and Vision Science. 58(10). 859–869. 32 indexed citations
19.
Criswell, Mark H., Chester J. Karwoski, & Luis M. Proenza. (1979). Species differences in the intraretinal electroretinogram within the leopard frog complex. Vision Research. 19(3). 339–341. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026